您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

血管生成抑制剂SU6668联合5-Fu对人结肠癌裸鼠移植瘤肝转移的影响

丁印鲁1,付勤烨1,唐思锋1,王静源1,张建良1,李占元2,李兆亭2   

  1. 山东大学 1. 第二医院普通外科, 山东 济南250033; 2. 齐鲁医院普通外科, 山东 济南 250012
  • 收稿日期:2006-09-04 修回日期:1900-01-01 出版日期:2007-02-24 发布日期:2007-02-24
  • 通讯作者: 丁印鲁

Inhibitory effect on liver metastasis

DING Yin-lu1,FU Qin-ye1,TANG Si-feng1,WANG Jing-yuan1,ZHANG Jian-liang1,LI Zhan-yuan2,LI Zhao-ting2   

  1. 1.Department of General Surgery, Second Hospital of Shandong University;2.Department of General Surgery, Qilu Hospital of Shandong University
  • Received:2006-09-04 Revised:1900-01-01 Online:2007-02-24 Published:2007-02-24
  • Contact: DING Yin-lu

摘要: 目的:探讨血管生成抑制剂SU6668联合5-Fu对人结肠癌肝转移的抑制作用。方法:将结肠癌HT-29细胞注入裸鼠脾脏,建立结肠癌肝转移模型。将裸鼠随机分为联合治疗组、SU6668组、5-Fu组和对照组4组。治疗6周后,处死裸鼠,计数肝转移率和肝转移结节数。采用免疫组化SABC法和图像分析系统对肝转移肿瘤组织的微血管密度(microvessel density, MVD)、血管内皮生长因子(vascular endothelial growth factor, VEGF)、碱性成纤维细胞生长因子(base fibroblast growth factor, bFGF)的表达进行定量分析。结果:各组转移率依次下降,差异有统计学意义(P<0.01);在肝转移结节数目比较上,对照组结节数大于20个时各组裸鼠所占比例差异有统计学意义(P<0.01)。联合治疗组和SU6668组分别与5-Fu组及对照组相比,MVD均显著减少(P<0.05)。联合治疗组、SU6668组、5-Fu组与对照组比较,VEGF、bFGF均显著降低,且联合治疗组、SU6668组、5-Fu组3组间差异有统计学意义(P<0.05)。结论:SU6668通过抗血管生成抑制结肠癌的肝转移,与5Fu联合应用具有协同效应,为安全有效的抗肿瘤策略。

Abstract: Objective: To study the effect of the angiogenesis inhibitor SU6668 combined with 5-Fu on liver metastasis in human colon cancer. Methods: The human colon cancer cell line, HT-29 cells were injected intrasplenically into BALB/c nude mice to make the diffuse liver metastasis model.Mice were randomly divided into four groups: SU6668 treatment group, 5-Fu treatment group, SU6668+5-Fu treatment group and control group. Animals were sacrificed after 7 weeks, and their livers were processed for histological examination. Liver metastasis rate and tumor foci in liver were counted. Tumor microvessel density(MVD) and vascular endothelial growth factor(VEGF), and base fibroblast growth factor (bFGF) were determined by the immunohistochemistry SABC method with an image analysis system. Results: SU6668 combined with 5-Fu and SU6668 alone displayed a significant inhibitory effect on liver metastasis compared with the control(P<0.01), and a significant decrease of the expression of VEGF and bFGF compared with the control(P<0.05). The expression of MVD was also inhibited by SU6668 in combination with 5-Fu or SU6668 alone compared with the control(P<0.05). Conclusion: The angiogenesis inhibitor SU6668 in combination with 5-Fu has an additive effect and inhibitory activity against liver metastasis of human colon cancer, therefore, it might be a safe and effective antitumor strategy.

Key words: Neovascularization, pathologic, 5-Fu, Colon neoplasms, Liver metastasis, Mice, inbred BALB C

中图分类号: 

  • R730.5
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!